|
|
41
|
|
|
B421M
|
|
|
DAPAGLIFLOZIN 5MG TAB (MCP)
|
|
|
DAPAGLIFLOZIN
|
|
|
DAPAGLIFLOZIN
|
|
|
100'S
|
|
|
A
|
|
|
34.44
|
|
|
0.3444
|
|
|
5MG
|
|
|
TAB
|
|
|
30
|
|
|
BLIS
|
|
|
MCP
|
|
|
MACLEODS PHARMACEUTICALS LTD
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
B
|
|
|
Anti-Diabetic
|
|
|
2024-10-29
|
|
|
2026-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
682018
|
|
|
SODIUM-GLUCOSE COTRANSPORTER INHIBITOR
|
|
|
|
|
|
ORAL
|
|
|
6
|
|
|
SODIUM-GLUCOSE COTRANSPORTER INHIBITOR
|
|
|
2024-09-20
|